ASXL1andCBLmutations are independently predictive of inferior survival in advanced systemic mastocytosis-Reference-Cited by-同舟云学术

ASXL1andCBLmutations are independently predictive of inferior survival in advanced systemic mastocytosis

Published:2015-12-02 Issue:3 Volume:175 Page:534-536
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Pardanani Animesh D.¹,Lasho Terra L.¹,Finke Christy¹,Zblewski Darci L.¹,Abdelrahman Ramy A.¹,Wassie Emnet A.¹,Gangat Naseema¹,Hanson Curtis A.²,Ketterling Rhett P.³,Tefferi Ayalew¹

Affiliation:

1. Division of Hematology; Department of Internal Medicine; Mayo Clinic; Rochester MN USA

2. Division of Hematopathology; Department of Laboratory Medicine and Pathology; Mayo Clinic; Rochester MN USA

3. Division of Cytogenetics; Department of Laboratory Medicine and Pathology; Mayo Clinic; Rochester MN USA

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13865/fullpdf

Reference10 articles.

1. Clinical effect of point mutations in myelodysplastic syndromes;Bejar;New England Journal of Medicine,2011

2. Concurrent activating KIT mutations in systemic mastocytosis;Lasho;British Journal of Haematology,2015

3. Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors;Lim;Blood,2009

4. Systemic mastocytosis in adults: 2015 update on diagnosis, risk stratification, and management;Pardanani;American Journal of Hematology,2015

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review and Updates on Systemic Mastocytosis and Related Entities;Cancers;2023-11-28

2. Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM Registry;Blood Advances;2023-04-27

3. The international consensus classification of mastocytosis and related entities;Virchows Archiv;2022-10-10

4. Update on diagnostic approaches and therapeutic strategies in systemic mastocytosis;Best Practice & Research Clinical Haematology;2022-06

5. Clinical impact and proposed application of molecular markers, genetic variants, and cytogenetic analysis in mast cell neoplasms: Status 2022;Journal of Allergy and Clinical Immunology;2022-06